CD8A and type 1 diabetes mellitus: However, they reported a reduction in autoreactive antigen-specific CD8+ T cells, but since this could only be observed in a small subset with large individual variability, the authors concluded that oral butyrate may not have a beneficial effect on immune cells in T1D patients and is not in line with previous animal studies [71].